Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
5.81
+0.18 (3.20%)
At close: Apr 28, 2026, 4:00 PM EDT
5.92
+0.11 (1.89%)
After-hours: Apr 28, 2026, 6:06 PM EDT
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $430.45 million as of April 28, 2026. Its market cap has increased by 497.53% in one year.
Market Cap
430.45M
Enterprise Value
256.94M
1-Year Change
497.53%
Ranking
Category
Stock Price
$5.81
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $430.45M, an increase of 58.63%. That is a compound annual growth rate of 20.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 416.74M | -42.50% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Assembly Biosciences | 436.54M |
| Benitec Biopharma | 431.95M |
| Atea Pharmaceuticals | 427.04M |
| Neurogene | 422.41M |
| PureTech Health | 412.93M |
| Invivyd | 412.89M |
| Neumora Therapeutics | 405.57M |
| Century Therapeutics | 405.13M |